The Global Women’s Health Diagnostics Market is expected to grow at a CAGR of more than 7.9% during the forecast period 2019-2026. The market was valued around $28 billion in the year 2018.
- Increasing prevalence of chronic and lifestyle disorders
- Increasing demand for point of care diagnostic testing centers
- Rise in adoption of diagnostics imaging procedures to diagnose diseases due to increasing awareness in regards to women’s diseases
- Government initiatives towards promoting health awareness among female population
- High cost of diagnostics tests
- Lack of skilled professionals
- Boost in Healthcare infrastructure globally
- Technological advancements focusing miniaturing the test devices size
Market Players profiled in the Research Report
Biomerieux SA, Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Alere Inc., Perkinelmer Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Quest Diagnostics Inc. and Siemens AG are some major key players included in the research study. Company profile section of the research report detailed about the company overview, SWOT analysis, product portfolio, business and financial performance and other key elements.
Biomerieux SA was founded in the year 1963 and the company is based in France. The company is specialized in in-vitro diagnostics for industrial and medical applications. The company sells, manufactured, develops and designs clinical applications systems for diagnosis of various diseases that include respiratory infections, tuberculosis and others. Considering industrial applications, the analysis of environmental and industrial samples can also be tested in the systems offered by the company. The services segment of the company includes maintenance and installation of various instruments for end-users. The company operated through its various subsidiaries including a new bi-plate Petri dish, chromID CARBA SMART, BioFire Diagnostics Inc., bioMerieux Benelux SA/NV, Advencis, bioMerieux Austria GmbH and bioMerieux Deutschland GmbH.
November 2018, Acquisition: BioMerieux acquired majority of stakes in Suxhou Hybiome Biomedical Engineering Co. Ltd, i.e. 54% of the company’s share. The acquisition was focused to provide automated solutions for healthcare solution providers. The strategic decision will allow bioMérieux group to accelerate the company’s growth in the market.
Abbott Laboratories was founded in the year 1888 and the company is based in the United States. The company is involved in the sale, manufacture, development and discovery of wide range of healthcare products. The major business segments of the company are Vascular Products, Nutritional Products, Pharmaceutical Products and Diagnostic Products. The Diagnostic Products segment offers various tests systems and diagnostic systems.
Becton, Dickinson and Company
Becton, Dickinson and Company was founded in the year 1897 and the company is based in the United States. The company is involved in sale, manufacture and development of a wide range of diagnostic products, laboratory equipment and medical devices. The business segment of the company includes BD Life Sciences and BD Medical. Company provide various solutions for customers that include medication for patient safety, infection prevention practices, interventional procedures, anesthesiology care and others. The company is also involved in providing anesthesiology care, advancing cellular research, managing the diagnosis of infectious diseases, managing the diagnosis of cancer and diabetes. The company operate through its subsidiaries that include Dantor S.A., Vital Signs Hong Kong Limited, CareFusion Canada 307 ULC, BD Norge AS and Accuri Cytometers, Inc.